论文部分内容阅读
目的为了进一步提高心肌梗死后左心力衰竭患者的治疗效果和减少各种不良事件的发生率,分析和探讨多巴胺联合硝普钠治疗的价值和意义。方法选取抽取56例于2014年1月-2015年1月医院治疗的心肌梗死后左心力衰竭患者作为研究对象,并按照随机数字表将患者分为试验组和对照组各28例,入组的所有患者均按照常规方案进行治疗,而试验患者则同时给予多巴胺联合硝普钠,比较不同治疗方案的疗效差异。结果 2组治疗后其心功能较治疗前均有所改善,且试验组患者改善较对照组更显著,差异具有统计学意义(P<0.05)。结论心肌梗死后左心力衰竭患者在常规治疗的基础上加用多巴胺联合硝普钠治疗,能够明显提高临床预后,改善患者的心功能,值得推广和应用。
Objective To further improve the therapeutic effect of left heart failure patients after myocardial infarction and reduce the incidence of various adverse events, analyze and explore the value and significance of dopamine combined with sodium nitroprusside. Methods Fifty-six patients with left heart failure after myocardial infarction were treated in our hospital from January 2014 to January 2015. The patients were divided into experimental group and control group according to random number table All patients were treated according to the conventional protocol, while patients were given dopamine combined with sodium nitroprusside to compare the efficacy of different treatment options. Results The cardiac function of the two groups was improved after treatment, and the improvement of the experimental group was more significant than that of the control group, the difference was statistically significant (P <0.05). Conclusions Patients with left heart failure after myocardial infarction combined with dopamine and sodium nitroprusside on the basis of routine treatment can significantly improve clinical prognosis and improve patients’ cardiac function, which deserves promotion and application.